Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus;Rituximab en el tratamiento del síndrome del pulmón encogido del lupus eritematoso sistémico

Reumatologia Clinica

Volumn 10, Issue 5, 2014, Pages 325-327

  Peñacoba Toribio, Patricia ^a   Córica Albani, María Emilia ^a   Mayos Pérez, Mercedes ^b   Rodríguez de la Serna, Arturo ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Glucocorticoids; Rituximab; Shrinking lung syndrome; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB; ANTIRHEUMATIC AGENT;

ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; HUMAN; SHRINKING LUNG SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; COMPLICATION; DYSPNEA; FEMALE; LUNG DISEASES; MIDDLE AGED; SYNDROME;

ANTIRHEUMATIC AGENTS; DYSPNEA; FEMALE; HUMANS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RITUXIMAB; SYNDROME;

EID: 84906506986     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2013.09.003     Document Type: Article

References (10)

1. Calderaro D.C., Ferreira G.A. Presentation and prognosis of shrinking lung syndrome in systemic lupus erythematosus: Report of four cases. Rheumatol Int 2012, 32:1391-1396.
2. Gheita T.A., Azkalany G.S., El-Fishawy H.S., Nour Eldin A.M. Shrinking lung syndrome in systemic lupus erythematosus patients; clinical characteristics, disease activity and damage. Int J Rheum Dis 2011, 14:361-368.
3. Toya S.P., Tzelepis G.E. Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: A systematic review. Semin Arthritis Rheum 2009, 39:30-37.
4. Pego-Reigosa J.M., Medeiros D.A., Isenberg D.A. Respiratory manifestations of systemic lupus erythematosus: Old and new concepts. Best Pract Res Clin Rheumatol 2009, 23:469-480.
5. Hawkins P., Davison A.G., Dasgupta B., Moxham J. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax 2001, 56:329-330.
6. Hoffbrand B.I., Beck E.R. "Unexplained"' dyspnoea and shrinking lungs in systemic lupus erythematosus. Br Med J 1965, 1:1273-1277.
7. Souza Neves F., da Silva T.H., Paviani G., Fontes Zimmermann A., de Castro G.R., Alves Pereira I. Reinforcing a medical hypothesis with a new question: Is there a subgroup of shrinking lungs syndrome that is induced by pleurisy in systemic lupus erythematosus and is this subgroup marked by anti-Ro/SSA?. Clin Rheumatol 2010, 29:777-779.
8. Carmier D., Diot E., Diot P. Shrinking lung syndrome: Recognition, pathophysiology and therapeutic strategy. Expert Rev Respir Med 2011, 5:33-39.
9. Vilaplana-Garcia R., Trujillo-Santos A.J., Vera-Mendez F.J. Shrinking lung syndrome: A rare manifestation of systemic lupus erythematosus. Arch Bronconeumol 2008, 44:341-342.
10. Benham H., Garske L., Vecchio P., Eckert B.W. Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus. J Clin Rheumatol 2010, 16:68-70.